Xenetic Biosciences Current Valuation vs. Operating Margin
| XBIO Stock | USD 4.20 0.15 3.45% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.77 | 0.89 |
|
|
For Xenetic Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Xenetic Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Xenetic Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Xenetic Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Xenetic Biosciences over time as well as its relative position and ranking within its peers.
Xenetic |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenetic Biosciences. If investors know Xenetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenetic Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Revenue Per Share 1.638 | Quarterly Revenue Growth 0.116 | Return On Assets (0.29) | Return On Equity (0.49) |
The market value of Xenetic Biosciences is measured differently than its book value, which is the value of Xenetic that is recorded on the company's balance sheet. Investors also form their own opinion of Xenetic Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Xenetic Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenetic Biosciences' market value can be influenced by many factors that don't directly affect Xenetic Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenetic Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenetic Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenetic Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Xenetic Biosciences Operating Margin vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Xenetic Biosciences's current stock value. Our valuation model uses many indicators to compare Xenetic Biosciences value to that of its competitors to determine the firm's financial worth. Xenetic Biosciences is rated below average in current valuation category among its peers. It is rated third in operating margin category among its peers . At this time, Xenetic Biosciences' Operating Profit Margin is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xenetic Biosciences' earnings, one of the primary drivers of an investment's value.Xenetic Current Valuation vs. Competition
Xenetic Biosciences is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 1.06 Billion. Xenetic Biosciences has negative current valuation of (160,295) making less than 1% of the industry.
Xenetic Operating Margin vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Xenetic Biosciences |
| = | (160.29 K) |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Xenetic Biosciences |
| = | (1.84) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Xenetic Operating Margin Comparison
Xenetic Biosciences is currently under evaluation in operating margin category among its peers.
Xenetic Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Xenetic Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Xenetic Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Xenetic Biosciences' change in net profit over the period of time. It can combine multiple indicators of Xenetic Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 228.4 K | 311.7 K | |
| Operating Income | -4.5 M | -4.7 M | |
| Income Before Tax | -4.1 M | -4.3 M | |
| Total Other Income Expense Net | 381.1 K | 400.2 K | |
| Net Loss | -4.1 M | -4.3 M | |
| Income Tax Expense | 28.2 K | 26.8 K | |
| Net Loss | -4.4 M | -4.7 M | |
| Non Operating Income Net Other | (565.80) | (594.09) | |
| Net Loss | -6.5 M | -6.8 M | |
| Net Interest Income | 351.8 K | 369.4 K | |
| Interest Income | 351.8 K | 369.4 K | |
| Change To Netincome | 369.4 K | 350.9 K | |
| Net Loss | (2.71) | (2.84) | |
| Income Quality | 1.00 | 1.04 | |
| Net Income Per E B T | 1.12 | 1.10 |
Xenetic Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Xenetic Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Xenetic Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Xenetic Biosciences' important profitability drivers and their relationship over time.
Use Xenetic Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xenetic Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xenetic Biosciences will appreciate offsetting losses from the drop in the long position's value.Xenetic Biosciences Pair Trading
Xenetic Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Xenetic Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xenetic Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xenetic Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xenetic Biosciences to buy it.
The correlation of Xenetic Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xenetic Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xenetic Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xenetic Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Xenetic Biosciences position
In addition to having Xenetic Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Business Supplies Thematic Idea Now
Business Supplies
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Supplies theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist. To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
To fully project Xenetic Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Xenetic Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Xenetic Biosciences' income statement, its balance sheet, and the statement of cash flows.